{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:41:15Z","timestamp":1789533675041,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.7759\/cureus.98425","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:57:18Z","timestamp":1764835038000},"source":"Crossref","is-referenced-by-count":1,"title":["Investigating the Increasing Azole Resistance in Candida Infections Among Critically Ill Patients: Experience From a Tertiary-Level Setup in North India"],"prefix":"10.7759","author":[{"given":"Sweta","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Islahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalicharan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva S","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012, 36:288-305. 10.1111\/j.1574-6976.2011.00278.x","journal-title":"FEMS Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/615958","article-title":"Non-albicans Candida infection: an emerging threat","volume":"2014","author":"Deorukhkar SC","year":"2014","unstructured":"Deorukhkar SC, Saini S, Mathew S. Non-albicans Candida infection: an emerging threat. Interdiscip Perspect Infect Dis. 2014, 2014:615958. 10.1155\/2014\/615958","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref3","article-title":"Candida auris","author":"Sikora A","year":"2025","unstructured":"Sikora A, Hashmi MF, Zahra F. Candida auris. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226675","article-title":"Candida auris: epidemiology update and a review of strategies to prevent spread","volume":"13","author":"Hayes JF","year":"2024","unstructured":"Hayes JF. Candida auris: epidemiology update and a review of strategies to prevent spread. J Clin Med. 2024, 13:6675. 10.3390\/jcm13226675","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy054","article-title":"Candida auris: the recent emergence of a multidrug-resistant fungal pathogen","volume":"57","author":"Forsberg K","year":"2019","unstructured":"Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2019, 57:1-12. 10.1093\/mmy\/myy054","journal-title":"Med Mycol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00577-18","article-title":"Five-year national surveillance of invasive Candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study","volume":"56","author":"Xiao M","year":"2018","unstructured":"Xiao M, Sun ZY, Kang M, et al.. Five-year national surveillance of invasive Candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018, 56:00577-18. 10.1128\/JCM.00577-18","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myx077","article-title":"Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study","volume":"56","author":"Breda GL","year":"2018","unstructured":"Breda GL, Tuon FF, Meis JF, et al.. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study. Med Mycol. 2018, 56:406-15. 10.1093\/mmy\/myx077","journal-title":"Med Mycol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micron.2011.09.013","article-title":"Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics","volume":"43","author":"Paiva LC","year":"2012","unstructured":"Paiva LC, Vidigal PG, Donatti L, Svidzinski TI, Consolaro ME. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron. 2012, 43:497-502. 10.1016\/j.micron.2011.09.013","journal-title":"Micron"},{"key":"ref9","unstructured":"CLSI. reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI guideline M27-S4. (2012). Accessed: September 23, 2025: https:\/\/clsi.org\/shop\/standards\/m27\/."},{"key":"ref10","unstructured":"CLSI. Performance standards for antifungal susceptibility testing of YeastsCLSI Guideline M27M44S. (2022). Accessed. September 23, 2025: https:\/\/clsi.org\/shop\/standards\/m27m44s\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/biology12070997","article-title":"Next-generation sequencing technology: current trends and advancements","volume":"12","author":"Satam H","year":"2023","unstructured":"Satam H, Joshi K, Mangrolia U, et al.. Next-generation sequencing technology: current trends and advancements. Biology (Basel). 2023, 12:997. 10.3390\/biology12070997","journal-title":"Biology (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02155-13","article-title":"Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011","volume":"58","author":"Guinea J","year":"2014","unstructured":"Guinea J, Zaragoza \u00d3, Escribano P, Mart\u00edn-Mazuelos E, Pem\u00e1n J, S\u00e1nchez-Reus F, Cuenca-Estrella M. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother. 2014, 58:1529-37. 10.1128\/AAC.02155-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality","volume":"41","author":"Bassetti M","year":"2015","unstructured":"Bassetti M, Righi E, Ansaldi F, et al.. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015, 41:1601-10. 10.1007\/s00134-015-3866-2","journal-title":"Intensive Care Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jof8020116","article-title":"Increasing incidence and shifting epidemiology of candidemia in Greece: results from the first nationwide 10-year survey","volume":"8","author":"Mamali V","year":"2022","unstructured":"Mamali V, Siopi M, Charpantidis S, Samonis G, Tsakris A, Vrioni G. Increasing incidence and shifting epidemiology of candidemia in Greece: results from the first nationwide 10-year survey. J Fungi (Basel). 2022, 8:116. 10.3390\/jof8020116","journal-title":"J Fungi (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study","volume":"87","author":"Arendrup MC","year":"2023","unstructured":"Arendrup MC, Arikan-Akdagli S, J\u00f8rgensen KM, et al.. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study. J Infect. 2023, 87:428-37. 10.1016\/j.jinf.2023.08.001","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01001-20","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar A","year":"2020","unstructured":"Arastehfar A, Daneshnia F, Hilmio\u011flu-Polat S, et al.. First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey. Antimicrob Agents Chemother. 2020, 64:01001-20. 10.1128\/AAC.01001-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040259","article-title":"Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian Cancer Referral Center","volume":"7","author":"Thomaz DY","year":"2021","unstructured":"Thomaz DY, de Almeida JN Jr, Sejas ON, et al.. Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian Cancer Referral Center. J Fungi (Basel). 2021, 7:259. 10.3390\/jof7040259","journal-title":"J Fungi (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1125241","article-title":"High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: an ignored matter of concern","volume":"14","author":"Fan X","year":"2023","unstructured":"Fan X, Tsui CK, Chen X, Wang P, Liu ZJ, Yang CX. High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: an ignored matter of concern. Front Microbiol. 2023, 14:1125241. 10.3389\/fmicb.2023.1125241","journal-title":"Front Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.03.018","article-title":"Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres","volume":"25","author":"Favarello LM","year":"2021","unstructured":"Favarello LM, Nucci M, Queiroz-Telles F, et al.. Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres. J Glob Antimicrob Resist. 2021, 25:199-201. 10.1016\/j.jgar.2021.03.018","journal-title":"J Glob Antimicrob Resist"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02242-21","article-title":"Antifungal resistance trends of Candida auris clinical isolates in New York and New Jersey from 2016 to 2020","volume":"66","author":"Kilburn S","year":"2022","unstructured":"Kilburn S, Innes G, Quinn M, et al.. Antifungal resistance trends of Candida auris clinical isolates in New York and New Jersey from 2016 to 2020. Antimicrob Agents Chemother. 2022, 66:e0224221. 10.1128\/aac.02242-21","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jof10040285","article-title":"Enhancing Candida auris surveillance in high-risk settings by implementing a high-throughput molecular assay on the hologic fusion open access platform","volume":"10","author":"Cerqueira FM","year":"2024","unstructured":"Cerqueira FM, Bertsch J, DeMaet MA, York T, McDougal A, Patel JA, Ren P. Enhancing Candida auris surveillance in high-risk settings by implementing a high-throughput molecular assay on the hologic fusion open access platform. J Fungi (Basel). 2024, 10:285. 10.3390\/jof10040285","journal-title":"J Fungi (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020322","article-title":"MALDI-TOF MS: a reliable tool in the real life of the clinical microbiology laboratory","volume":"12","author":"Calderaro A","year":"2024","unstructured":"Calderaro A, Chezzi C. MALDI-TOF MS: a reliable tool in the real life of the clinical microbiology laboratory. Microorganisms. 2024, 12:322. 10.3390\/microorganisms12020322","journal-title":"Microorganisms"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01827-20","article-title":"Monitoring the epidemiology and antifungal resistance of yeasts causing fungemia in a tertiary care hospital in Madrid, Spain: any relevant changes in the last 13 years?","volume":"65","author":"D\u00edaz-Garc\u00eda J","year":"2021","unstructured":"D\u00edaz-Garc\u00eda J, Mesquida A, S\u00e1nchez-Carrillo C, Reigadas E, Mu\u00f1oz P, Escribano P, Guinea J. Monitoring the epidemiology and antifungal resistance of yeasts causing fungemia in a tertiary care hospital in Madrid, Spain: any relevant changes in the last 13 years?. Antimicrob Agents Chemother. 2021, 65:01827-20. 10.1128\/AAC.01827-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.04.003","article-title":"\u0394F659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata","volume":"28","author":"Mesquida A","year":"2022","unstructured":"Mesquida A, D\u00edaz-Garc\u00eda J, S\u00e1nchez-Carrillo C, et al.. \u0394F659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata. Clin Microbiol Infect. 2022, 28:1154.e5-8. 10.1016\/j.cmi.2022.04.003","journal-title":"Clin Microbiol Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434586-investigating-the-increasing-azole-resistance-in-candida-infections-among-critically-ill-patients-experience-from-a-tertiary-level-setup-in-north-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:57:20Z","timestamp":1764835040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434586-investigating-the-increasing-azole-resistance-in-candida-infections-among-critically-ill-patients-experience-from-a-tertiary-level-setup-in-north-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.98425","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}